Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.09M Sell
2,751
-3,581
-57% -$1.02M 0.02% 327
2026
Q1
$1.1M Sell
6,332
-290
-4% -$59.4K 0.03% 332
2025
Q4
$1.7M Sell
6,622
-2,905
-30% -$762K 0.04% 302
2025
Q3
$2.48M Hold
9,527
0.06% 220
2025
Q2
$2.33M Hold
9,527
0.07% 221
2025
Q1
$2.53M Sell
9,527
-420
-4% -$114K 0.08% 206
2024
Q4
$2.52M Buy
+9,947
New +$2.67M 0.07% 209

Other funds holding HUM

Avanza Fonder's HUM Position: Q2 2026 in Review

Avanza Fonder reduced its Humana (HUM) stake by 57% in Q2 2026, selling an estimated $1.02M and leaving 2,751 shares worth $1.09M. The position accounts for 0.02% of the portfolio, ranked #327.

Avanza Fonder first reported a position in HUM in Q4 2024 and has held it in 7 quarters since. The position peaked at $2.53M in Q1 2025. 183 funds tracked by Wall St. Rank hold HUM as of Q2 2026.

  • Avanza Fonder held 2,751 shares of Humana worth $1.09M as of Q2 2026.
  • Avanza Fonder sold 3,581 Humana shares in Q2 2026, an estimated $1.02M.
  • Humana made up 0.02% of Avanza Fonder's portfolio in Q2 2026, its #327 holding.
  • Avanza Fonder first reported a position in Humana in Q4 2024 and has held it in 7 quarters since.
  • Avanza Fonder's Humana position peaked at $2.53M in Q1 2025.
  • 183 funds tracked by Wall St. Rank held Humana as of Q2 2026.

Based on Avanza Fonder's 13F filing for Q2 2026, filed 17 Jul 2026.